Gayathri Srinivasan

Title: Innovations in Cancer Treatment by Gayathri Srinivasan

Introduction

Gayathri Srinivasan is an accomplished inventor based in Gainesville, FL (US). She has made significant contributions to the field of cancer therapeutics, particularly through her innovative research and patent.

Latest Patents

Srinivasan holds a patent titled "Use of miR-223-3p as a cancer therapeutic and method for treating cancer using the same." This patent describes a pharmaceutical composition that includes an inhibitory RNA (iRNA) capable of mediating sequence-specific degradation of the mRNA encoding Poly (ADP-ribose) polymerase 1 (PARP1). The invention outlines methods for treating various cancers, including breast, ovarian, prostate, pancreatic cancers, and mesothelioma, by administering this pharmaceutical composition to patients in need. The iRNA, specifically miR-223-3p, can be modified with substitutions or deletions to enhance its therapeutic efficacy.

Career Highlights

Srinivasan is affiliated with the University of Florida Research Foundation Inc., where she continues her research in cancer treatment. Her work has garnered attention for its potential to improve therapeutic outcomes for patients with specific genetic mutations, such as those in the BRCA1 and BRCA2 genes.

Collaborations

Some of her notable coworkers include Robert A. Hromas and Elizabeth Williamson, who have contributed to her research endeavors.

Conclusion

Gayathri Srinivasan's innovative work in cancer therapeutics exemplifies the impact of research on improving treatment options for patients. Her patent on miR-223-3p highlights the potential of RNA-based therapies in addressing complex cancer challenges.